Patent ID: 11873283
Assignee: CELGENE CORPORATION
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 0:
1. A compound of formula (I), or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein
RN is H;
each R1 is independently selected from halogen, CN, and C1-3 alkyl;
R2 and R3 are each independently selected from H, and C1-3 alkyl, or R2 and R3 and the carbon to which they are attached form a substituted or unsubstituted C3-6 cycloalkyl;
each R4 is independently substituted or unsubstituted C1-3 alkyl, or two R4 groups, together with the same carbon atom or adjacent carbon atoms to which they are attached, form a substituted or unsubstituted C3-6 cycloalkyl, or two R4 groups together with the non-adjacent carbon atoms to which they are attached form a substituted or unsubstituted 4-7-membered heterocyclyl;
X is N;
L is —O(C1-6 alkyl)- or —(C1-9 alkyl)-;
n is 0-4;
m is 0-8;
V is, wherein
A is N, CH, or CRA;
B is N, CH, or CRB;
each RA is independently selected from halogen, substituted or unsubstituted C1-6 alkyl, and substituted or unsubstituted C3-6 cycloalkyl;
each RB is independently selected from halogen, and substituted or unsubstituted C1-6 alkyl;
RC is halogen or CF3;
R5 and R6 are C1-3 alkyl, or R5 and R6, together with the carbon atom to which they are attached, form a substituted or unsubstituted C3-6 cycloalkyl or a 3-6 membered heterocyclyl;
a is 0-3; and
b is 0-2.